Cantor Fitzgerald Maintains Neutral Rating and $2 PT on Novavax (NOVA) Following Mixed Q4 Results
Tweet Send to a Friend
Cantor Fitzgerald analyst William Tanner maintains Neutral rating and $2 price target on Novavax Inc. (NASDAQ: NVAX), as the company ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
